1 Department of Pharmaceutical Chemistry, Srujan Foundations, G. D. Burkule Institute of Research and Education in Pharmaceutical Sciences, Cidco Nashik Maharashtra, India.
2 Department of Pharmaceutical Chemistry, METs Institute of D Pharmacy, Adgaon Nashik Maharashtra, India.
World Journal of Biology Pharmacy and Health Sciences, 2025, 21(01), 547-560
Article DOI: 10.30574/wjbphs.2025.21.1.0072
Received on 07 December 2024; revised on 23 January 2025; accepted on 26 January 2025
In recent years, C. auris has become a leading source of invasive fungal diseases, with outbreaks occurring across all continents. This fungus infection poses a severe hazard to healthcare, with outbreaks primarily affecting older patients with comorbidities and high fatality rates. Controlling epidemics has been challenging because to poor detection, fast spread, and resistance to environmental cleaning methods. C. auris is currently the major cause, or one of the leading causes of invasive fungal infections in many healthcare facilities, primarily due to its potential may exhibit or acquire resistance to many types of antifungal medications and due to their Ability to persevere in healthcare circumstances. Timely diagnosis by swift and reliable identification. techniques and dedication in infection control procedures can assist to limit the spread of C. auris, and prevent and manage epidemics
Candida Auris; Antimicrobial Resistance; Environmental Conditions; Treatments; Hospital Outbreaks
Preview Article PDF
Vaishnavi V Khairnar, Yogesh S Wankhede and Amol R Patil. Candida Auris: Review on worldwide spread, seems prone to antifungal and disinfectant therapies. World Journal of Biology Pharmacy and Health Sciences, 2025, 21(01), 547-560. Article DOI: https://doi.org/10.30574/wjbphs.2025.21.1.0072.
Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0